Viewing StudyNCT02254551



Ignite Creation Date: 2024-05-06 @ 3:17 AM
Last Modification Date: 2024-10-26 @ 11:31 AM
Study NCT ID: NCT02254551
Status: TERMINATED
Last Update Posted: 2017-02-16
First Post: 2014-09-29

Brief Title: SafetyEfficacy Study of LDE225 Sonidegib Plus Bortezomib in Patients With Relapsed or RelapsedRefractory Multiple Myeloma
Sponsor: SCRI Development Innovations LLC
Organization: SCRI Development Innovations LLC

Conditions & Keywords Data

Conditions:
Name
Multiple Myeloma
Keywords:
Name View
Velcade View
relapsed multiple myeloma View
refractory multiple myeloma View
LDE225 View
Sonidegib View
bortezomib View
smoothened SMO inhibitors View